SCYNEXIS, Inc. (SCYX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1160370,
    "name": "SCYNEXIS, Inc.",
    "stock_name": "SCYNEXIS, Inc.",
    "full_name": "SCYNEXIS, Inc.",
    "name_url": "stocks-analysis/scynexis-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.67",
    "chg": 0.01,
    "chgp": "1.83%",
    "dir": 1,
    "prev_price": "0.66",
    "mcapval": "38.45",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US8112922005",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "307.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/scynexis-inc-1160370-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is SCYNEXIS, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-scynexis-inc-technically-bullish-or-bearish-3546476",
        "imagepath": "",
        "date": "2025-09-20 19:33:47",
        "description": "As of 11 September 2025, the technical trend for SCYNEXIS, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish. The RSI shows no signal on the weekly chart but is bullish on the monthly. However, the daily moving averages are mildly bearish, and the KST indicates a bearish monthly trend. Additionally, the Bollinger Bands present a mildly bullish signal on the weekly but a mildly bearish signal on the monthly.\n\nIn terms of performance, SCYNEXIS has underperformed the S&P 500 across multiple periods, with a 1-week return of -7.63% compared to the S&P 500's 1.05%, and a 1-year return of -30.57% versus the S&P 500's 17.14%. Overall, the mixed signals suggest a cautious approach is warranted...."
      },
      {
        "title": "Is SCYNEXIS, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-scynexis-inc-overvalued-or-undervalued-3543047",
        "imagepath": "",
        "date": "2025-09-20 18:09:13",
        "description": "As of 8 August 2024, the valuation grade for SCYNEXIS, Inc. has moved from attractive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. Key ratios include a Price to Book Value of 0.71, an EV to EBIT of 0.13, and an EV to EBITDA of 0.13, all of which suggest that the company is struggling to generate positive returns relative to its valuation.\n\nIn comparison to peers, SCYNEXIS, Inc. has a notably low EV to EBITDA ratio of 0.13, while CytomX Therapeutics, Inc., which is rated very attractive, boasts a much higher EV to EBITDA of 4.6280. Other peers such as Chimerix, Inc. and Aquestive Therapeutics, Inc. also show negative valuations, but SCYNEXIS's performance stands out as particularly weak. Additionally, the company's stock has underperformed significantly compared to the S&P 500, with a year-t..."
      }
    ],
    "total": 7,
    "sid": "1160370",
    "stock_news_url": "https://www.marketsmojo.com/news/scynexis-inc-1160370"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is SCYNEXIS, Inc. technically bullish or bearish?

2025-09-20 19:33:47

As of 11 September 2025, the technical trend for SCYNEXIS, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish. The RSI shows no signal on the weekly chart but is bullish on the monthly. However, the daily moving averages are mildly bearish, and the KST indicates a bearish monthly trend. Additionally, the Bollinger Bands present a mildly bullish signal on the weekly but a mildly bearish signal on the monthly. In terms of performance, SCYNEXIS has underperformed the S&P 500 across multiple periods, with a 1-week return of -7.63% compared to the S&P 500's 1.05%, and a 1-year return of -30.57% versus the S&P 500's 17.14%. Overall, the mixed signals suggest a cautious approach is warranted....

Is SCYNEXIS, Inc. overvalued or undervalued?

2025-09-20 18:09:13

As of 8 August 2024, the valuation grade for SCYNEXIS, Inc. has moved from attractive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. Key ratios include a Price to Book Value of 0.71, an EV to EBIT of 0.13, and an EV to EBITDA of 0.13, all of which suggest that the company is struggling to generate positive returns relative to its valuation. In comparison to peers, SCYNEXIS, Inc. has a notably low EV to EBITDA ratio of 0.13, while CytomX Therapeutics, Inc., which is rated very attractive, boasts a much higher EV to EBITDA of 4.6280. Other peers such as Chimerix, Inc. and Aquestive Therapeutics, Inc. also show negative valuations, but SCYNEXIS's performance stands out as particularly weak. Additionally, the company's stock has underperformed significantly compared to the S&P 500, with a year-t...

View All News